Exposure–Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting

René J. Boosman*, Merel Jebbink, Wouter B. Veldhuis, Stefanie L. Groenland, Bianca A.M.H. van Veggel, Pim Moeskops, Adrianus J. de Langen, Jos H. Beijnen, Egbert F. Smit, Alwin D.R. Huitema, Neeltje Steeghs

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Exposure–Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science